EUVIMEDEUVIMED entdecken
Crossref

Elegibilidad de fármacos en terapias de reemplazo hormonal para mujeres climatéricas hipertensas: una revisión de alcance

Benjamín A. Medina-Ramírez, Matías F. Henríquez-Ortiz

Revista Chilena de Obstetricia y Ginecología · 28.05.2026 · 90 (5)

DOI: 10.24875/rechog.25000002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Revista Chilena de Obstetricia y Ginecología, online erschienen am 28.05.2026. Verfasst von Benjamín A. Medina-Ramírez und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Climacteric is a stage in a woman’s life that occurs between the ages of 45-64 years, where fertility decline begins. The transition towards menopause represents the process in which fertility declines progressively, beginning around the age of 30 and culminating with menopause (between 45 and 55 years), marking the end of the reproductive period. In this population, there is a high prevalence of arterial hypertension. In Chile, there are no clinical guidelines for the treatment of climacteric symptoms with hormone replacement therapy (HRT) and menopausal hormone therapy (MHT), which uses minimal effective doses to alleviate symptoms, that provide specific indications for hypertensive women. The aim of this research is to explore the existing evidence of HRT regimens for hypertensive climacteric women in Organisation for Economic Co-operation and Development countries. A systematic search was conducted using MeSH and DeCS terms in PubMed, LILACS, Embase, SciELO, Google and Google Scholar databases since 2002, oriented to the Joanna Briggs Institute guidelines for the organization of the search. Combined HRT-MHT was shown to reduce blood pressure, improve menopausal symptoms and have beneficial effects on renal function. The use of combined hormonal therapies was highlighted as having benefits on cardiovascular health in hypertensive women. HRT-MHT with 17β-estradiol and drospirenone shows promising results. Further research is needed to define optimal approaches for hypertensive women.

Zitieren

APA

Medina-Ramírez, B. A., & Henríquez-Ortiz, M. F. (2026). Elegibilidad de fármacos en terapias de reemplazo hormonal para mujeres climatéricas hipertensas: una revisión de alcance. Revista Chilena de Obstetricia y Ginecología, 90(5). https://doi.org/10.24875/rechog.25000002

Vancouver

Medina-Ramírez BA, Henríquez-Ortiz MF. Elegibilidad de fármacos en terapias de reemplazo hormonal para mujeres climatéricas hipertensas: una revisión de alcance. Revista Chilena de Obstetricia y Ginecología. 2026;90(5). doi:10.24875/rechog.25000002

BibTeX
@article{MedinaRamrez2026,
  author = {Medina-Ramírez, Benjamín A. and Henríquez-Ortiz, Matías F.},
  title = {Elegibilidad de fármacos en terapias de reemplazo hormonal para mujeres climatéricas hipertensas: una revisión de alcance},
  journal = {Revista Chilena de Obstetricia y Ginecología},
  year = {2026},
  volume = {90},
  number = {5},
  doi = {10.24875/rechog.25000002}
}
Kostenlos starten →